Plus Therapeutics, Inc.

Plus Therapeutics, Inc. - Enterprise Valueverified

PSTV

Price:

$3.87

Market Cap:

$13.97M

Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses. A cornerstone of their pipeline is Rhenium-186 NanoLiposome (R-186 NL), a patented radiotherapy specifically engineered to address difficult central nervous system (CNS) cancers, such as recurrent glioblastoma, leptomeningeal metastases, and various brain cancers affecting children. The company has also secured a licensing agreement with NanoTx, Corp. to advance and commercialize NanoTx's treatment for glioblastoma. Founded in 1996 and headquartered in Austin...[Read more]

Industry

Biotechnology

IPO Date

2001-07-11

Stock Exchange

NASDAQ

Ticker

PSTV

The Enterprise Value as of September 2026 (TTM) for Plus Therapeutics, Inc. (PSTV) is 11.65M

According to Plus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.65M. This represents a change of -1.98% compared to the average of 11.89M of the last 4 quarters.

Plus Therapeutics, Inc. (PSTV) Historical Enterprise Value (quarterly & annually)

How has PSTV Enterprise Value performed in the past?

The mean historical Enterprise Value of Plus Therapeutics, Inc. over the last ten years is -794407.58. The current 11.65M Enterprise Value has changed -146759.14% with respect to the historical average. Over the past ten years (40 quarters), PSTV's Enterprise Value was at its highest in in the June 2026 quarter at 25.11M. The Enterprise Value was at its lowest in in the March 2022 quarter at -14457767.72.

Quarterly (TTM)
Annual

Average

-794407.58

Median

1.36M

Minimum

-12364716.44

Maximum

8.94M

Plus Therapeutics, Inc. (PSTV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Plus Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 744.98%

Maximum Annual Enterprise Value = 8.94M

Minimum Annual Increase = -199.87%

Minimum Annual Enterprise Value = -12364716.44

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20254.67M6.88%
20244.37M-199.87%
2023-4372491.17-64.64%
2022-12364716.448.40%
2021-11406869.63744.98%
2020-1349952.18-75.80%
2019-5578985.05-162.40%
20188.94M119.46%
20174.07M-19.80%
20165.08M114.72%

Plus Therapeutics, Inc. (PSTV) Average Enterprise Value

How has PSTV Enterprise Value performed in the past?

The current Enterprise Value of Plus Therapeutics, Inc. (PSTV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.55M

5-year avg

-3822002.31

10-year avg

-794407.58

Plus Therapeutics, Inc. (PSTV) Enterprise Value vs. Peers

How is PSTV’s Enterprise Value compared to its peers?

Plus Therapeutics, Inc.’s Enterprise Value is greater than Aditxt, Inc. (8.95M), greater than Baudax Bio, Inc. (1.86M), less than Edesa Biotech, Inc. (29.55M), greater than MetaVia Inc. (-8956698.00), greater than Phio Pharmaceuticals Corp. (-1146405.00), greater than Hoth Therapeutics, Inc. (9.87M),

CompanyEnterprise ValueMarket cap
8.95M$4.99M
1.86M$4.36K
29.55M$39.88M
-8956698.00$3.50M
-1146405.00$11.85M
9.87M$17.76M

Build a custom stock screener for Plus Therapeutics, Inc. (PSTV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Plus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Plus Therapeutics, Inc. (PSTV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Plus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Plus Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Plus Therapeutics, Inc. (PSTV)?

What is the 3-year average Enterprise Value for Plus Therapeutics, Inc. (PSTV)?

What is the 5-year average Enterprise Value for Plus Therapeutics, Inc. (PSTV)?

How does the current Enterprise Value for Plus Therapeutics, Inc. (PSTV) compare to its historical average?